Arrhythmias in a patient with metastatic melanoma treated with targeted therapy and implantable cardioverter defibrillator

Br J Dermatol. 2017 Aug;177(2):584-587. doi: 10.1111/bjd.15447. Epub 2017 Jun 22.

Authors

M Licciardello¹, M T Giura¹, G Rozzo¹, E Marra¹, P Fava¹, C Astrua¹, V Contu², P Lista², M T Fierro¹, P Quaglino¹, S Ribero¹

Affiliations

¹ Dermatology Unit, Department of Medical Sciences, University of Turin, Corso Dogliotti, 14, 10126, Turin, Italy.
² Medical Oncology Division, University Hospital Città della Salute e della Scienza, Turin, Italy.

PMID: 28295195
DOI: 10.1111/bjd.15447

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Adult
Antineoplastic Agents / administration & dosage
Arrhythmias, Cardiac / therapy*
Defibrillators, Implantable*
Heart Neoplasms / secondary
Heart Neoplasms / therapy*
Humans
Imidazoles / administration & dosage
Male
Melanoma / secondary*
Melanoma / therapy
Molecular Targeted Therapy / methods*
Oximes / administration & dosage
Positron Emission Tomography Computed Tomography
Protein Kinase Inhibitors / therapeutic use
Pyridones / administration & dosage
Pyrimidinones / administration & dosage
Skin Neoplasms*

Substances

Antineoplastic Agents
Imidazoles
Oximes
Protein Kinase Inhibitors
Pyridones
Pyrimidinones
trametinib
dabrafenib